Sanofi
40,79 $Veränderung zum vorherigen Schlusskurs: −1,07 %Absolute Veränderung: −0,44 $
Aktuelle Nachrichten
Schlagzeilen in der Originalsprache der Quelle.
- Sanofi pays Regeneron USD 1bn upfront in immunology deal (öffnet in neuem Tab)
- Friday Five: Sanofi and Regeneron (re)partner up in the face of Dupixent's patent cliff, AstraZeneca invests $2B in Summit, Lilly delivers more weight loss wins…and more (öffnet in neuem Tab)
- Sanofi and Regeneron expand alliance with $8bn immunology deal (öffnet in neuem Tab)
- Regeneron, Sanofi Expand Alliance in Deal Worth Up to $8 Billion (öffnet in neuem Tab)
- Sanofi Puts Up $1B to Expand Regeneron Alliance and Develop Next-Gen Dupixent (öffnet in neuem Tab)
- Sanofi To Pay Regeneron Up To $8B In Immunology Alliance (öffnet in neuem Tab)
- Sanofi And Regeneron Expand Immunology Alliance In Deal Worth Up To $8 Billion (öffnet in neuem Tab)
- REGN Stock In Focus: Sanofi Expands Immunology Deal With $1B Upfront Payment And 4 New Antibodies (öffnet in neuem Tab)
- Regeneron And Sanofi Announce A Win-Win Collaboration Expansion (NASDAQ:REGN) (öffnet in neuem Tab)
- Sanofi, Regeneron expand tie-up with $8 billion drug-development deal, settle legal dispute (öffnet in neuem Tab)
- Sanofi and Regeneron expand global alliance (öffnet in neuem Tab)
- Sanofi, Regeneron deepen decadeslong alliance with $8B deal (öffnet in neuem Tab)
- Regeneron, Sanofi Expand Alliance with $1 Billion Upfront, 4 Antibodies (öffnet in neuem Tab)
- Four long-acting antibodies anchor Sanofi (SNY)'s expanded alliance with Regeneron. (öffnet in neuem Tab)
- Sanofi, Regeneron broaden alliance to find their next Dupixent (öffnet in neuem Tab)
- Spotlight On: Sanofi and Regeneron get cosy again as they look to build on Dupixent success (öffnet in neuem Tab)
- Sanofi Deepens 20-Year Drug Development Pact With Regeneron, Pledges Up to $8 Billion (öffnet in neuem Tab)
- Regeneron and Sanofi Expand Antibody Alliance with Four New Drugs (öffnet in neuem Tab)
- Sanofi, Regeneron to Expand Alliance in Up to $8 Billion Deal (öffnet in neuem Tab)
- Sanofi, Regeneron Expand DUPIXENT Alliance in Deal Worth Up to €8 Billion (öffnet in neuem Tab)
- Sanofi, Regeneron expand partnership after Dupixent success (öffnet in neuem Tab)
- Sanofi pays $1B upfront to expand immunology deal with Regeneron (öffnet in neuem Tab)
- Sanofi pays Regeneron $1B upfront to continue search for Dupixent successor (öffnet in neuem Tab)
- Sanofi commits up to USD 8b for Regeneron’s long-acting immunology antibodies (öffnet in neuem Tab)
- Sanofi forges new $8bn pact with Regeneron (öffnet in neuem Tab)
- Sanofi and Regeneron expand immunology partnership to the tune of $8bn (öffnet in neuem Tab)
- Sanofi to invest up to $8bn to expand alliance with Regeneron (öffnet in neuem Tab)
- Sanofi builds on immunology alliance with Regeneron for $1B upfront (öffnet in neuem Tab)
- Sanofi pays $1B upfront to expand Regeneron alliance beyond Dupixent (öffnet in neuem Tab)
- Sanofi gains after expanding Regeneron partnership with $8 billion deal (öffnet in neuem Tab)